Brain Tumors
Precision Neurosurgery Meets Molecular Innovation

Brain Tumor treatment requires the ultimate in surgical precision and technological innovation to remove cancer while preserving neurological function. Our neurosurgical program includes awake craniotomies for tumors near critical brain areas, allowing real-time functional monitoring during surgery to maximize tumor removal while protecting speech, movement, and cognitive function.

Advanced radiation therapy including stereotactic radiosurgery enables treatment of multiple brain metastases in single sessions with sub-millimeter precision. Molecular characterization of brain tumors guides treatment selection, with IDH-mutated gliomas, MGMT-methylated tumors, and other molecular subtypes requiring different therapeutic approaches. Novel drug delivery methods overcome the blood-brain barrier challenge, enabling effective treatment of previously untreatable brain tumors.

Leukemia and Lymphoma
Revolutionary Blood Cancer Breakthroughs

Leukemia/Lymphoma treatment has been revolutionized by cellular therapy breakthroughs, particularly CAR-T cell therapy that engineers patients’ own immune cells to fight blood cancers with unprecedented effectiveness. Our comprehensive blood cancer program addresses all types of leukemia and lymphoma with treatments ranging from traditional chemotherapy to cutting-edge cellular therapies.

Advanced stem cell transplantation techniques, including haploidentical approaches that expand donor options, provide curative potential for many patients. Novel targeted therapies including BTK inhibitors, BCL-2 inhibitors, and immunomodulatory drugs have transformed treatment for specific blood cancer subtypes, often converting fatal diagnoses into manageable chronic conditions.

Breast Cancer
Precision Meets Preservation

Breast Cancer treatment at Neovita combines surgical excellence with molecular precision to achieve optimal outcomes while preserving femininity and quality of life. Our comprehensive approach integrates advanced surgical techniques, targeted therapies matched to specific tumor subtypes (hormone receptor-positive, HER2-positive, triple-negative), and innovative approaches including CDK4/6 inhibitors, antibody-drug conjugates, and personalized immunotherapy.

Through our Cancer Center for Women, we provide specialized care that understands the unique physical, emotional, and social aspects of breast cancer treatment. Our multidisciplinary team includes breast surgeons specializing in oncoplastic techniques, medical oncologists with expertise in precision medicine, radiation oncologists using advanced techniques like accelerated partial breast irradiation, and comprehensive support services including genetic counseling, fertility preservation, and reconstruction coordination.

Lung Cancer
Breathing New Life into Treatment

Lung Cancer care has been transformed by molecular medicine, with treatment strategies now guided by specific genetic alterations including EGFR mutations, ALK rearrangements, ROS1 alterations, BRAF mutations, and numerous other targetable alterations. Our comprehensive molecular profiling identifies the optimal targeted therapy for each patient, often achieving dramatic responses even in advanced disease.

Our thoracic surgery program utilizes minimally invasive and robotic techniques that enable complete cancer removal while preserving maximum lung function. Advanced radiation therapy including stereotactic body radiation therapy (SBRT) provides highly effective treatment for early-stage disease and oligometastatic cases. Immunotherapy combinations, including checkpoint inhibitors and novel immune-activating approaches, have revolutionized treatment for patients without targetable mutations.

Prostate Cancer
Preserving Function While Defeating Cancer

Prostate Cancer treatment focuses on achieving cure while preserving the functions that define quality of life for men—urinary control, sexual function, and overall vitality. Our precision radiation therapy program includes techniques that can track prostate movement in real-time, delivering high doses to cancer while avoiding nearby organs.

Advanced surgical approaches including robotic-assisted procedures enable complete cancer removal through minimally invasive techniques. For men with advanced disease, we offer the complete arsenal of hormone therapies, targeted treatments for specific genetic alterations, and novel immunotherapy approaches. Our comprehensive men’s health program addresses all aspects of prostate cancer care, from active surveillance for low-risk disease to complex multimodal treatment for advanced cases.

Colorectal Cancer
Precision Surgery Meets Molecular Medicine

Colorectal Cancer treatment combines surgical excellence with precision medicine approaches based on molecular tumor characteristics. Our robotic surgery program enables complex cancer removal through minimally invasive approaches, often preserving bowel function and avoiding permanent ostomies when possible.

Molecular testing guides treatment selection, identifying tumors with microsatellite instability that respond dramatically to immunotherapy, BRAF mutations vulnerable to targeted combination treatments, and other genetic alterations that predict optimal therapy selection. Advanced approaches to treating liver metastases have transformed what was once a terminal diagnosis into potentially curable disease.

Pancreatic Cancer
Confronting Medicine’s Greatest Challenge

Pancreatic Cancer represents one of oncology’s most formidable challenges, requiring extraordinary expertise and innovative approaches. Our surgical program includes complex procedures like the Whipple operation performed through minimally invasive and robotic approaches when appropriate, often enabling surgery for tumors other centers might consider inoperable.

Advanced systemic therapy approaches include combinations that attack both cancer cells and the dense fibrous barrier that protects pancreatic tumors from treatment. Immunotherapy combinations, targeted treatments for specific genetic alterations including BRCA mutations, and novel drug delivery approaches provide new hope for patients facing this challenging diagnosis.